Cargando…

Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment

AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates. They present several characteristics. They are easy to produce, they present very small hydrodynamic diameters (<5 nm) and they are biodegradable through hydrolysis of siloxane bonds. Such degradation was...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Duc, Géraldine, Roux, Stéphane, Paruta-Tuarez, Amandine, Dufort, Sandrine, Brauer, Elke, Marais, Arthur, Truillet, Charles, Sancey, Lucie, Perriat, Pascal, Lux, François, Tillement, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631720/
https://www.ncbi.nlm.nih.gov/pubmed/26561512
http://dx.doi.org/10.1186/s12645-014-0004-8
_version_ 1782398890386915328
author Le Duc, Géraldine
Roux, Stéphane
Paruta-Tuarez, Amandine
Dufort, Sandrine
Brauer, Elke
Marais, Arthur
Truillet, Charles
Sancey, Lucie
Perriat, Pascal
Lux, François
Tillement, Olivier
author_facet Le Duc, Géraldine
Roux, Stéphane
Paruta-Tuarez, Amandine
Dufort, Sandrine
Brauer, Elke
Marais, Arthur
Truillet, Charles
Sancey, Lucie
Perriat, Pascal
Lux, François
Tillement, Olivier
author_sort Le Duc, Géraldine
collection PubMed
description AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates. They present several characteristics. They are easy to produce, they present very small hydrodynamic diameters (<5 nm) and they are biodegradable through hydrolysis of siloxane bonds. Such degradation was evaluated in diluted conditions at physiological pH by dynamic light scattering and relaxometry. AGuIX nanoparticles are also known as positive contrast agents and efficient radiosensitizers. The aim of this paper is to compare their efficiency for magnetic resonance imaging and radiosensitization to those of the commercial gadolinium based molecular agent: DOTAREM®. An experiment with healthy animals was conducted and the MRI pictures we obtained show a better contrast with the AguIX compared to the DOTAREM® for the same amount of injected gadolinium in the animal. The better contrast obtained after injection of Aguix than DOTAREM® is due to a higher longitudinal relaxivity and a residential time in the blood circulation that is two times higher. A fast and large increase in the contrast is also observed by MRI after an intravenous injection of the AGuIX in 9 L gliosarcoma bearing rats, and a plateau is reached seven minutes after the injection. We established a radiotherapy protocol consisting of an irradiation by microbeam radiation therapy 20 minutes after the injection of a specific quantity of gadolinium. After microbeam radiation therapy, no notable difference in median survival time was observed in the presence or absence of gadolinium chelates (38 and 44 days respectively). In comparison, the median survival time is increased to 102.5 days with AGuIX particles showing their interest in this nanomedicine protocol. This remarkable radiosensitizing effect could be explained by the persistent tumor uptake of the particles, inducing a significant nanoscale dose deposition under irradiation.
format Online
Article
Text
id pubmed-4631720
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-46317202015-11-09 Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment Le Duc, Géraldine Roux, Stéphane Paruta-Tuarez, Amandine Dufort, Sandrine Brauer, Elke Marais, Arthur Truillet, Charles Sancey, Lucie Perriat, Pascal Lux, François Tillement, Olivier Cancer Nanotechnol Research AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates. They present several characteristics. They are easy to produce, they present very small hydrodynamic diameters (<5 nm) and they are biodegradable through hydrolysis of siloxane bonds. Such degradation was evaluated in diluted conditions at physiological pH by dynamic light scattering and relaxometry. AGuIX nanoparticles are also known as positive contrast agents and efficient radiosensitizers. The aim of this paper is to compare their efficiency for magnetic resonance imaging and radiosensitization to those of the commercial gadolinium based molecular agent: DOTAREM®. An experiment with healthy animals was conducted and the MRI pictures we obtained show a better contrast with the AguIX compared to the DOTAREM® for the same amount of injected gadolinium in the animal. The better contrast obtained after injection of Aguix than DOTAREM® is due to a higher longitudinal relaxivity and a residential time in the blood circulation that is two times higher. A fast and large increase in the contrast is also observed by MRI after an intravenous injection of the AGuIX in 9 L gliosarcoma bearing rats, and a plateau is reached seven minutes after the injection. We established a radiotherapy protocol consisting of an irradiation by microbeam radiation therapy 20 minutes after the injection of a specific quantity of gadolinium. After microbeam radiation therapy, no notable difference in median survival time was observed in the presence or absence of gadolinium chelates (38 and 44 days respectively). In comparison, the median survival time is increased to 102.5 days with AGuIX particles showing their interest in this nanomedicine protocol. This remarkable radiosensitizing effect could be explained by the persistent tumor uptake of the particles, inducing a significant nanoscale dose deposition under irradiation. Springer Vienna 2014-07-01 2014 /pmc/articles/PMC4631720/ /pubmed/26561512 http://dx.doi.org/10.1186/s12645-014-0004-8 Text en © Le Duc et al.; licensee Springer 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Le Duc, Géraldine
Roux, Stéphane
Paruta-Tuarez, Amandine
Dufort, Sandrine
Brauer, Elke
Marais, Arthur
Truillet, Charles
Sancey, Lucie
Perriat, Pascal
Lux, François
Tillement, Olivier
Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
title Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
title_full Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
title_fullStr Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
title_full_unstemmed Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
title_short Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
title_sort advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by mri for glioma treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631720/
https://www.ncbi.nlm.nih.gov/pubmed/26561512
http://dx.doi.org/10.1186/s12645-014-0004-8
work_keys_str_mv AT leducgeraldine advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT rouxstephane advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT parutatuarezamandine advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT dufortsandrine advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT brauerelke advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT maraisarthur advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT truilletcharles advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT sanceylucie advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT perriatpascal advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT luxfrancois advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment
AT tillementolivier advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment